Dr. George Letsou presents CorInnova's preclinical data at CSI Focus D-HF Congress in Frankfurt, Germany

Reviews in Cardiovascular Medicine: The CorInnova Implantable Cardiac Assist System for Direct Cardiac Compression

CorInnova joins MedTech Innovator's 2022 Cohort in Tenth Year of World’s Largest MedTech Accelerator Program

CorInnova Selected as Finalist at Prestigious Annual Medical Device Competition

William Altman presents at TCT 2021 session "Emerging Technological Trends III: Interventional Heart Failure and Neuromodulation Therapies"

CorInnova presents at LSI Emerging Medtech Summit 2021 on May 11-13 

Dr. George Letsou presents CorInnova’s latest results at CSI FOCUS D-HF Mechanical Circulatory Support 

CorInnova Presents at Transcatheter Cardiovascular Therapeutics Conference - TCT Connect 2020

CorInnova presents at 2020 Society of Thoracic Surgeons Annual Meeting’s Tech-Con Shark Tank

CorInnova presents at 2019 CSI D-HF Device Therapies for Heart Failure in Paris

TMC Innovation Institute selects CorInnova for TMCx09 Medical Device Cohort

CorInnova invited to speak at BIOMEDevice Boston

CorInnova wins "Best Investment Potential - Top 3 All Industries" at 2019 Angel Capital Association Meeting

CorInnova Wins 2019 MedCity INVEST PitchPerfect Competition

Two TMC-Backed Startups Aim to Change the Way We Treat Failing Hearts

CorInnova's Preclinical results to date published in prestigious Journal for Translational Cardiovascular Research

CorInnova invited to speak at CSI D-HF Device Therapies for Heart Failure in Frankfurt

“STS/AATS Tech-Con 2018” – Sixth Honor in Five Months

CorInnova Wins Top Prize at “RESI San Francisco 2018” Innovation Challenge

CorInnova Awarded “2017 InnoSTARS” Prize for Non-Blood-Contacting, Soft Robotic Heart Assist Device as Alternative to LVAD Treatment of Heart Failure

CorInnova wins “Most Promising Life Science Company” award from Rice Alliance for Technology and Entrepreneurship at Texas Life Science Forum

CorInnova Selected to Present at TCT 2017 “Shark Tank” Competition

$6.1 Million Lead Investment from UK-based The Wellcome Trust is being Used to Develop Less-Invasive, Non-Blood-Contacting Soft Robotic Heart Device to Treat Heart Failure.

CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device to Support Heart Function

Company Announces Residency at Johnson & Johnson Innovation’s JLABS @ TMC in the Texas Medical Center